Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorPrisma Health-Upstate
About this trial
This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.
Eligibility criteria
Qualifiers
Adults aged 21 years or older.
Current e-cigarette users who report e-cigarette use on ≥20 of the past 30 days.
Former daily cigarette smokers who currently smoke on ≤19 days per month and no more than 5 cigarettes per day.
Diagnosed with opioid use disorder (OUD).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Sweet-cooling
- Sweet non-cooling EC flavor
- Tobacco flavor EC
Treatment groups
No treatment groups listed
Sponsors and collaborators
Prisma Health-Upstate
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov